Ocular Therapeutix to participate in September and October conferences
Ocular Therapeutix, Inc. (NASDAQ: OCUL) announced it will participate in upcoming investor and scientific conferences in September and October.
BEDFORD, Mass., Sept.
01, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming investor and scientific conferences in September and October…